JAAD International (Jun 2023)

Mapping the burden of severe forms of epidermolysis bullosa – Implications for patient managementCapsule Summary

  • Jemima E. Mellerio, MD,
  • Dimitra Kiritsi, MD, PhD,
  • M. Peter Marinkovich, MD,
  • Natividad Romero Haro, RN,
  • Kellie Badger, RN,
  • Meena Arora, MSc,
  • Marc A. Dziasko, PhD,
  • Mansi Vithlani, PhD,
  • Anna E. Martinez

Journal volume & issue
Vol. 11
pp. 224 – 232

Abstract

Read online

Background: The pathophysiological processes underlying the phenotypic spectrum of severe forms of epidermolysis bullosa (EB) are complex and poorly understood. Objective: To use burden mapping to explore relationships between primary pathomechanisms and secondary clinical manifestations in severe forms of EB (junctional and dystrophic EB [JEB/DEB]) and highlight strengths and weaknesses in evidence regarding the contribution of different pathways. Methods: Literature searches were performed to identify evidence regarding the pathophysiological and clinical aspects of JEB/DEB. Identified publications and clinical experience were used to construct burden maps to visually communicate plausible connections and their relative importance by subtype. Results: Our findings suggest that most of the clinical consequences of JEB/DEB may result from an abnormal state and/or faulty skin remodeling driven by a vicious cycle of delayed wound healing, predominantly mediated through inflammation. The quantity and quality of evidence varies by individual manifestations and disease subtype. Limitations: The burden maps are provisional hypotheses requiring further validation and are limited by the published evidence base and subjectivity in clinical opinion. Conclusions: Delayed wound healing appears to be a key driver of the burden of JEB/DEB. Further studies are warranted to understand the role of inflammatory mediators and accelerated wound healing in patient management.

Keywords